Intellectual Asset Management (IAM) has again included Gibbons P.C. in its 2017 edition of IAM Patent 1000: The World’s Leading Patent Professionals.
David E. De Lorenzi, Chair of the Gibbons Intellectual Property Department, and Department Counsel George W. Johnston and George M. Gould were also recognized individually among IAM’s leading patent practitioners. This is the seventh straight year that IAM has recognized the firm.
To compile the IAM Patent 1000, the IAM team conducts extensive research over the course of five months with thousands of private practice attorneys based in dozens of countries, as well as the users of their services, in order to identify the practitioners and practices that are considered to excel at providing patent-related legal services.
Among other accolades, IAM recognized that “intellectual property is a central pillar at general practice Gibbons” while also recognizing that the firm’s IP experience “across the board means that patents are prosecuted with aplomb, technology transfers are swiftly sewn up and high-stakes cases are favourably resolved.” Moreover, clients surveyed by IAM remarked that when working with the Gibbons Intellectual Property Department, the client’s “long-term business interests are always kept front and centre.”
David E. De Lorenzi was again selected by IAM for his patent litigation and transactional practice: “David is a smart, sensible, practical and cost-effective attorney who gets superb results and whom clients trust. What is really impressive is the way he can move from zealous advocate in the courtroom to savvy negotiator if the time comes to settle. Excellent in all respects, he really brings a lot to the picture.”
Sources say of George W. Johnston: “Johnston stands out because he looks at things through the eyes of an in-house counsel and that’s really helpful. Management is one of his key strengths; another is his international knowledge. He is an excellent IP practitioner and on top of that is also a great guy.” Of George M. Gould, the publications notes “Formulating flawless strategies comes as second nature to Gould; of late, he has been doing just that in the pharmaceutical space …”